According to the regulation of CLEC5A on Akt phosphorylation in glioblastoma cell lines, we further determined whether inhibition of Akt by Akt pathway inhibitors or activation of AKT by insulin signalling agonist could reverse the effects conducted by CLEC5A shRNA knockdown or overexpression. This evidence concerns the gene CLEC5A and glioblastoma.